Regeneron Pharmaceuticals, Inc (REGN) is a biopharmaceutical company that develops medicines for the treatment of serious medical conditions. One the company’s treatments that looked promising early on was Kevzara. The drug was being tested alongside Sanofi (SNY), but early results of their IL-6 inhibitor hit hurdles in the U.S. following results, and the companies have […]